APO Research
Talk to an analyst

APO RESEARCH · REPORT

Defibrinated Animal Blood

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Defibrinated Animal Blood Market Analysis and Forecast 2026-2032

8 January 2026210 pages

Choose your research edition.

Industry ResearchDefibrinated Animal Blood Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Defibrinated Animal Blood Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Defibrinated Animal Blood Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Defibrinated Animal Blood Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Defibrinated Animal Blood Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Defibrinated Animal Blood market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Defibrinated Animal Blood is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Defibrinated Animal Blood is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Defibrinated Animal Blood is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Defibrinated Animal Blood is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Defibrinated Animal Blood include Thermo Fisher Scientific, TCS Biosciences, BioMérieux, E & O Laboratories Ltd, Southern Biological, Trafalgar Scientific, HemoStat Laboratories, Dutscher and Serana Europe, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Defibrinated Animal Blood, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Defibrinated Animal Blood, also provides the sales of main regions and countries. Of the upcoming market potential for Defibrinated Animal Blood, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Defibrinated Animal Blood sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Defibrinated Animal Blood market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Defibrinated Animal Blood sales, projected growth trends, production technology, application and end-user industry.

Defibrinated Animal Blood Segment by Company

Thermo Fisher Scientific

TCS Biosciences

BioMérieux

E & O Laboratories Ltd

Southern Biological

Trafalgar Scientific

HemoStat Laboratories

Dutscher

Serana Europe

Innovative Research Inc

Colorado Serum

SSI Diagnostica

SR Group

Szabo-Scandic

Rockland Immunochemicals, Inc.

LABone Scientific Co.Ltd.

Biowest(BioNordic A/S)

Pel-Freez Biologicals

EWC Diagnostics

Kraeber & Co. GmbH

Bio Nutrientes Do Brasil Ltda.

Lampire Biological Laboratories, Inc.

Quad Five(Materials Bio Inc.)

Guangzhou Ruite Biotechnology Co., Ltd.

Obio Technology (Shanghai) Corp., Ltd.

Beijing Solarbio Science & Technology Co.,Ltd.

Nanjing SenBeiJia Biological Technology Co., Ltd.

Changde BKMAM Biotechnology Co. Ltd.

Beijing Baiao Leibo Technology Co., Ltd.

Defibrinated Animal Blood Segment by Type

Bovine

Horse

Rabbit

Sheep

Others

Defibrinated Animal Blood Segment by Application

Biomedicine

Research

Defibrinated Animal Blood Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Defibrinated Animal Blood market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Defibrinated Animal Blood and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Defibrinated Animal Blood.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Defibrinated Animal Blood in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Defibrinated Animal Blood manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Defibrinated Animal Blood sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Defibrinated Animal Blood Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Bovine Major Manufacturers Table 3. Horse Major Manufacturers Table 4. Rabbit Major Manufacturers Table 5. Sheep Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Defibrinated Animal Blood Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Biomedicine Major Manufacturers Table 9. Research Major Manufacturers Table 10. Defibrinated Animal Blood Industry Trends Table 11. Defibrinated Animal Blood Industry Drivers Table 12. Defibrinated Animal Blood Industry Opportunities and Challenges Table 13. Defibrinated Animal Blood Industry Restraints Table 14. Global Defibrinated Animal Blood Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Defibrinated Animal Blood Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Defibrinated Animal Blood Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Defibrinated Animal Blood Revenue Market Share by Region (2021-2026) Table 18. Global Defibrinated Animal Blood Revenue Market Share by Region (2027-2032) Table 19. Global Defibrinated Animal Blood Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (kL) Table 20. Global Defibrinated Animal Blood Sales by Region (2021-2026) & (kL) Table 21. Global Defibrinated Animal Blood Sales by Region (2027-2032) & (kL) Table 22. Global Defibrinated Animal Blood Sales Market Share by Region (2021-2026) Table 23. Global Defibrinated Animal Blood Sales Market Share by Region (2027-2032) Table 24. Global Defibrinated Animal Blood Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Defibrinated Animal Blood Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Defibrinated Animal Blood Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Defibrinated Animal Blood Sales Market Share by Manufacturers (2021-2026) Table 28. Global Defibrinated Animal Blood Sales Price (USD/L) of Manufacturers (2021-2026) Table 29. Global Defibrinated Animal Blood Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Defibrinated Animal Blood Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Defibrinated Animal Blood Manufacturers, Product Type & Application Table 32. Global Defibrinated Animal Blood Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Defibrinated Animal Blood by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Defibrinated Animal Blood Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Defibrinated Animal Blood Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Defibrinated Animal Blood Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Defibrinated Animal Blood Revenue Market Share by Type (2021-2026) Table 39. Global Defibrinated Animal Blood Revenue Market Share by Type (2027-2032) Table 40. Global Defibrinated Animal Blood Sales by Type 2021 VS 2025 VS 2032 (kL) Table 41. Global Defibrinated Animal Blood Sales by Type (2021-2026) & (kL) Table 42. Global Defibrinated Animal Blood Sales by Type (2027-2032) & (kL) Table 43. Global Defibrinated Animal Blood Sales Market Share by Type (2021-2026) Table 44. Global Defibrinated Animal Blood Sales Market Share by Type (2027-2032) Table 45. Global Defibrinated Animal Blood Price by Type (2021-2026) & (USD/L) Table 46. Global Defibrinated Animal Blood Price by Type (2027-2032) & (USD/L) Table 47. Global Defibrinated Animal Blood Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Defibrinated Animal Blood Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Defibrinated Animal Blood Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Defibrinated Animal Blood Revenue Market Share by Application (2021-2026) Table 51. Global Defibrinated Animal Blood Revenue Market Share by Application (2027-2032) Table 52. Global Defibrinated Animal Blood Sales by Application 2021 VS 2025 VS 2032 (kL) Table 53. Global Defibrinated Animal Blood Sales by Application (2021-2026) & (kL) Table 54. Global Defibrinated Animal Blood Sales by Application (2027-2032) & (kL) Table 55. Global Defibrinated Animal Blood Sales Market Share by Application (2021-2026) Table 56. Global Defibrinated Animal Blood Sales Market Share by Application (2027-2032) Table 57. Global Defibrinated Animal Blood Price by Application (2021-2026) & (USD/L) Table 58. Global Defibrinated Animal Blood Price by Application (2027-2032) & (USD/L) Table 59. Thermo Fisher Scientific Company Information Table 60. Thermo Fisher Scientific Business Overview Table 61. Thermo Fisher Scientific Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 62. Thermo Fisher Scientific Defibrinated Animal Blood Product Portfolio Table 63. Thermo Fisher Scientific Recent Development Table 64. TCS Biosciences Company Information Table 65. TCS Biosciences Business Overview Table 66. TCS Biosciences Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 67. TCS Biosciences Defibrinated Animal Blood Product Portfolio Table 68. TCS Biosciences Recent Development Table 69. BioMérieux Company Information Table 70. BioMérieux Business Overview Table 71. BioMérieux Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 72. BioMérieux Defibrinated Animal Blood Product Portfolio Table 73. BioMérieux Recent Development Table 74. E & O Laboratories Ltd Company Information Table 75. E & O Laboratories Ltd Business Overview Table 76. E & O Laboratories Ltd Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 77. E & O Laboratories Ltd Defibrinated Animal Blood Product Portfolio Table 78. E & O Laboratories Ltd Recent Development Table 79. Southern Biological Company Information Table 80. Southern Biological Business Overview Table 81. Southern Biological Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 82. Southern Biological Defibrinated Animal Blood Product Portfolio Table 83. Southern Biological Recent Development Table 84. Trafalgar Scientific Company Information Table 85. Trafalgar Scientific Business Overview Table 86. Trafalgar Scientific Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 87. Trafalgar Scientific Defibrinated Animal Blood Product Portfolio Table 88. Trafalgar Scientific Recent Development Table 89. HemoStat Laboratories Company Information Table 90. HemoStat Laboratories Business Overview Table 91. HemoStat Laboratories Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 92. HemoStat Laboratories Defibrinated Animal Blood Product Portfolio Table 93. HemoStat Laboratories Recent Development Table 94. Dutscher Company Information Table 95. Dutscher Business Overview Table 96. Dutscher Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 97. Dutscher Defibrinated Animal Blood Product Portfolio Table 98. Dutscher Recent Development Table 99. Serana Europe Company Information Table 100. Serana Europe Business Overview Table 101. Serana Europe Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 102. Serana Europe Defibrinated Animal Blood Product Portfolio Table 103. Serana Europe Recent Development Table 104. Innovative Research Inc Company Information Table 105. Innovative Research Inc Business Overview Table 106. Innovative Research Inc Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 107. Innovative Research Inc Defibrinated Animal Blood Product Portfolio Table 108. Innovative Research Inc Recent Development Table 109. Colorado Serum Company Information Table 110. Colorado Serum Business Overview Table 111. Colorado Serum Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 112. Colorado Serum Defibrinated Animal Blood Product Portfolio Table 113. Colorado Serum Recent Development Table 114. SSI Diagnostica Company Information Table 115. SSI Diagnostica Business Overview Table 116. SSI Diagnostica Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 117. SSI Diagnostica Defibrinated Animal Blood Product Portfolio Table 118. SSI Diagnostica Recent Development Table 119. SR Group Company Information Table 120. SR Group Business Overview Table 121. SR Group Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 122. SR Group Defibrinated Animal Blood Product Portfolio Table 123. SR Group Recent Development Table 124. Szabo-Scandic Company Information Table 125. Szabo-Scandic Business Overview Table 126. Szabo-Scandic Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 127. Szabo-Scandic Defibrinated Animal Blood Product Portfolio Table 128. Szabo-Scandic Recent Development Table 129. Rockland Immunochemicals, Inc. Company Information Table 130. Rockland Immunochemicals, Inc. Business Overview Table 131. Rockland Immunochemicals, Inc. Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 132. Rockland Immunochemicals, Inc. Defibrinated Animal Blood Product Portfolio Table 133. Rockland Immunochemicals, Inc. Recent Development Table 134. LABone Scientific Co.Ltd. Company Information Table 135. LABone Scientific Co.Ltd. Business Overview Table 136. LABone Scientific Co.Ltd. Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 137. LABone Scientific Co.Ltd. Defibrinated Animal Blood Product Portfolio Table 138. LABone Scientific Co.Ltd. Recent Development Table 139. Biowest(BioNordic A/S) Company Information Table 140. Biowest(BioNordic A/S) Business Overview Table 141. Biowest(BioNordic A/S) Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 142. Biowest(BioNordic A/S) Defibrinated Animal Blood Product Portfolio Table 143. Biowest(BioNordic A/S) Recent Development Table 144. Pel-Freez Biologicals Company Information Table 145. Pel-Freez Biologicals Business Overview Table 146. Pel-Freez Biologicals Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 147. Pel-Freez Biologicals Defibrinated Animal Blood Product Portfolio Table 148. Pel-Freez Biologicals Recent Development Table 149. EWC Diagnostics Company Information Table 150. EWC Diagnostics Business Overview Table 151. EWC Diagnostics Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 152. EWC Diagnostics Defibrinated Animal Blood Product Portfolio Table 153. EWC Diagnostics Recent Development Table 154. Kraeber & Co. GmbH Company Information Table 155. Kraeber & Co. GmbH Business Overview Table 156. Kraeber & Co. GmbH Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 157. Kraeber & Co. GmbH Defibrinated Animal Blood Product Portfolio Table 158. Kraeber & Co. GmbH Recent Development Table 159. Bio Nutrientes Do Brasil Ltda. Company Information Table 160. Bio Nutrientes Do Brasil Ltda. Business Overview Table 161. Bio Nutrientes Do Brasil Ltda. Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 162. Bio Nutrientes Do Brasil Ltda. Defibrinated Animal Blood Product Portfolio Table 163. Bio Nutrientes Do Brasil Ltda. Recent Development Table 164. Lampire Biological Laboratories, Inc. Company Information Table 165. Lampire Biological Laboratories, Inc. Business Overview Table 166. Lampire Biological Laboratories, Inc. Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 167. Lampire Biological Laboratories, Inc. Defibrinated Animal Blood Product Portfolio Table 168. Lampire Biological Laboratories, Inc. Recent Development Table 169. Quad Five(Materials Bio Inc.) Company Information Table 170. Quad Five(Materials Bio Inc.) Business Overview Table 171. Quad Five(Materials Bio Inc.) Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 172. Quad Five(Materials Bio Inc.) Defibrinated Animal Blood Product Portfolio Table 173. Quad Five(Materials Bio Inc.) Recent Development Table 174. Guangzhou Ruite Biotechnology Co., Ltd. Company Information Table 175. Guangzhou Ruite Biotechnology Co., Ltd. Business Overview Table 176. Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 177. Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Animal Blood Product Portfolio Table 178. Guangzhou Ruite Biotechnology Co., Ltd. Recent Development Table 179. Obio Technology (Shanghai) Corp., Ltd. Company Information Table 180. Obio Technology (Shanghai) Corp., Ltd. Business Overview Table 181. Obio Technology (Shanghai) Corp., Ltd. Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 182. Obio Technology (Shanghai) Corp., Ltd. Defibrinated Animal Blood Product Portfolio Table 183. Obio Technology (Shanghai) Corp., Ltd. Recent Development Table 184. Beijing Solarbio Science & Technology Co.,Ltd. Company Information Table 185. Beijing Solarbio Science & Technology Co.,Ltd. Business Overview Table 186. Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 187. Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Animal Blood Product Portfolio Table 188. Beijing Solarbio Science & Technology Co.,Ltd. Recent Development Table 189. Nanjing SenBeiJia Biological Technology Co., Ltd. Company Information Table 190. Nanjing SenBeiJia Biological Technology Co., Ltd. Business Overview Table 191. Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 192. Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Animal Blood Product Portfolio Table 193. Nanjing SenBeiJia Biological Technology Co., Ltd. Recent Development Table 194. Changde BKMAM Biotechnology Co. Ltd. Company Information Table 195. Changde BKMAM Biotechnology Co. Ltd. Business Overview Table 196. Changde BKMAM Biotechnology Co. Ltd. Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 197. Changde BKMAM Biotechnology Co. Ltd. Defibrinated Animal Blood Product Portfolio Table 198. Changde BKMAM Biotechnology Co. Ltd. Recent Development Table 199. Beijing Baiao Leibo Technology Co., Ltd. Company Information Table 200. Beijing Baiao Leibo Technology Co., Ltd. Business Overview Table 201. Beijing Baiao Leibo Technology Co., Ltd. Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 202. Beijing Baiao Leibo Technology Co., Ltd. Defibrinated Animal Blood Product Portfolio Table 203. Beijing Baiao Leibo Technology Co., Ltd. Recent Development Table 204. North America Defibrinated Animal Blood Revenue by Type (2021-2026) & (US$ Million) Table 205. North America Defibrinated Animal Blood Revenue by Type (2027-2032) & (US$ Million) Table 206. North America Defibrinated Animal Blood Sales by Type (2021-2026) & (kL) Table 207. North America Defibrinated Animal Blood Sales by Type (2027-2032) & (kL) Table 208. North America Defibrinated Animal Blood Sales Price by Type (2021-2026) & (USD/L) Table 209. North America Defibrinated Animal Blood Sales Price by Type (2027-2032) & (USD/L) Table 210. North America Defibrinated Animal Blood Revenue by Application (2021-2026) & (US$ Million) Table 211. North America Defibrinated Animal Blood Revenue by Application (2027-2032) & (US$ Million) Table 212. North America Defibrinated Animal Blood Sales by Application (2021-2026) & (kL) Table 213. North America Defibrinated Animal Blood Sales by Application (2027-2032) & (kL) Table 214. North America Defibrinated Animal Blood Sales Price by Application (2021-2026) & (USD/L) Table 215. North America Defibrinated Animal Blood Sales Price by Application (2027-2032) & (USD/L) Table 216. North America Defibrinated Animal Blood Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 217. North America Defibrinated Animal Blood Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 218. North America Defibrinated Animal Blood Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 219. North America Defibrinated Animal Blood Sales by Country (2021 VS 2025 VS 2032) & (kL) Table 220. North America Defibrinated Animal Blood Sales by Country (2021-2026) & (kL) Table 221. North America Defibrinated Animal Blood Sales by Country (2027-2032) & (kL) Table 222. North America Defibrinated Animal Blood Sales Price by Country (2021-2026) & (USD/L) Table 223. North America Defibrinated Animal Blood Sales Price by Country (2027-2032) & (USD/L) Table 224. United States Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 225. Canada Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 226. Mexico Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 227. Europe Defibrinated Animal Blood Revenue by Type (2021-2026) & (US$ Million) Table 228. Europe Defibrinated Animal Blood Revenue by Type (2027-2032) & (US$ Million) Table 229. Europe Defibrinated Animal Blood Sales by Type (2021-2026) & (kL) Table 230. Europe Defibrinated Animal Blood Sales by Type (2027-2032) & (kL) Table 231. Europe Defibrinated Animal Blood Sales Price by Type (2021-2026) & (USD/L) Table 232. Europe Defibrinated Animal Blood Sales Price by Type (2027-2032) & (USD/L) Table 233. Europe Defibrinated Animal Blood Revenue by Application (2021-2026) & (US$ Million) Table 234. Europe Defibrinated Animal Blood Revenue by Application (2027-2032) & (US$ Million) Table 235. Europe Defibrinated Animal Blood Sales by Application (2021-2026) & (kL) Table 236. Europe Defibrinated Animal Blood Sales by Application (2027-2032) & (kL) Table 237. Europe Defibrinated Animal Blood Sales Price by Application (2021-2026) & (USD/L) Table 238. Europe Defibrinated Animal Blood Sales Price by Application (2027-2032) & (USD/L) Table 239. Europe Defibrinated Animal Blood Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 240. Europe Defibrinated Animal Blood Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 241. Europe Defibrinated Animal Blood Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 242. Europe Defibrinated Animal Blood Sales by Country (2021 VS 2025 VS 2032) & (kL) Table 243. Europe Defibrinated Animal Blood Sales by Country (2021-2026) & (kL) Table 244. Europe Defibrinated Animal Blood Sales by Country (2027-2032) & (kL) Table 245. Europe Defibrinated Animal Blood Sales Price by Country (2021-2026) & (USD/L) Table 246. Europe Defibrinated Animal Blood Sales Price by Country (2027-2032) & (USD/L) Table 247. Germany Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 248. France Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 249. U.K. Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 250. Italy Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 251. Russia Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 252. Spain Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 253. Netherlands Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 254. Switzerland Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 255. Sweden Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 256. Poland Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 257. China Defibrinated Animal Blood Revenue by Type (2021-2026) & (US$ Million) Table 258. China Defibrinated Animal Blood Revenue by Type (2027-2032) & (US$ Million) Table 259. China Defibrinated Animal Blood Sales by Type (2021-2026) & (kL) Table 260. China Defibrinated Animal Blood Sales by Type (2027-2032) & (kL) Table 261. China Defibrinated Animal Blood Sales Price by Type (2021-2026) & (USD/L) Table 262. China Defibrinated Animal Blood Sales Price by Type (2027-2032) & (USD/L) Table 263. China Defibrinated Animal Blood Revenue by Application (2021-2026) & (US$ Million) Table 264. China Defibrinated Animal Blood Revenue by Application (2027-2032) & (US$ Million) Table 265. China Defibrinated Animal Blood Sales by Application (2021-2026) & (kL) Table 266. China Defibrinated Animal Blood Sales by Application (2027-2032) & (kL) Table 267. China Defibrinated Animal Blood Sales Price by Application (2021-2026) & (USD/L) Table 268. China Defibrinated Animal Blood Sales Price by Application (2027-2032) & (USD/L) Table 269. Asia Defibrinated Animal Blood Revenue by Type (2021-2026) & (US$ Million) Table 270. Asia Defibrinated Animal Blood Revenue by Type (2027-2032) & (US$ Million) Table 271. Asia Defibrinated Animal Blood Sales by Type (2021-2026) & (kL) Table 272. Asia Defibrinated Animal Blood Sales by Type (2027-2032) & (kL) Table 273. Asia Defibrinated Animal Blood Sales Price by Type (2021-2026) & (USD/L) Table 274. Asia Defibrinated Animal Blood Sales Price by Type (2027-2032) & (USD/L) Table 275. Asia Defibrinated Animal Blood Revenue by Application (2021-2026) & (US$ Million) Table 276. Asia Defibrinated Animal Blood Revenue by Application (2027-2032) & (US$ Million) Table 277. Asia Defibrinated Animal Blood Sales by Application (2021-2026) & (kL) Table 278. Asia Defibrinated Animal Blood Sales by Application (2027-2032) & (kL) Table 279. Asia Defibrinated Animal Blood Sales Price by Application (2021-2026) & (USD/L) Table 280. Asia Defibrinated Animal Blood Sales Price by Application (2027-2032) & (USD/L) Table 281. Asia Defibrinated Animal Blood Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 282. Asia Defibrinated Animal Blood Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 283. Asia Defibrinated Animal Blood Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 284. Asia Defibrinated Animal Blood Sales by Country (2021 VS 2025 VS 2032) & (kL) Table 285. Asia Defibrinated Animal Blood Sales by Country (2021-2026) & (kL) Table 286. Asia Defibrinated Animal Blood Sales by Country (2027-2032) & (kL) Table 287. Asia Defibrinated Animal Blood Sales Price by Country (2021-2026) & (USD/L) Table 288. Asia Defibrinated Animal Blood Sales Price by Country (2027-2032) & (USD/L) Table 289. Japan Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 290. South Korea Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 291. India Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 292. Australia Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 293. Taiwan Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 294. Southeast Asia Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 295. SAMEA Defibrinated Animal Blood Revenue by Type (2021-2026) & (US$ Million) Table 296. SAMEA Defibrinated Animal Blood Revenue by Type (2027-2032) & (US$ Million) Table 297. SAMEA Defibrinated Animal Blood Sales by Type (2021-2026) & (kL) Table 298. SAMEA Defibrinated Animal Blood Sales by Type (2027-2032) & (kL) Table 299. SAMEA Defibrinated Animal Blood Sales Price by Type (2021-2026) & (USD/L) Table 300. SAMEA Defibrinated Animal Blood Sales Price by Type (2027-2032) & (USD/L) Table 301. SAMEA Defibrinated Animal Blood Revenue by Application (2021-2026) & (US$ Million) Table 302. SAMEA Defibrinated Animal Blood Revenue by Application (2027-2032) & (US$ Million) Table 303. SAMEA Defibrinated Animal Blood Sales by Application (2021-2026) & (kL) Table 304. SAMEA Defibrinated Animal Blood Sales by Application (2027-2032) & (kL) Table 305. SAMEA Defibrinated Animal Blood Sales Price by Application (2021-2026) & (USD/L) Table 306. SAMEA Defibrinated Animal Blood Sales Price by Application (2027-2032) & (USD/L) Table 307. SAMEA Defibrinated Animal Blood Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 308. SAMEA Defibrinated Animal Blood Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 309. SAMEA Defibrinated Animal Blood Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 310. SAMEA Defibrinated Animal Blood Sales by Country (2021 VS 2025 VS 2032) & (kL) Table 311. SAMEA Defibrinated Animal Blood Sales by Country (2021-2026) & (kL) Table 312. SAMEA Defibrinated Animal Blood Sales by Country (2027-2032) & (kL) Table 313. SAMEA Defibrinated Animal Blood Sales Price by Country (2021-2026) & (USD/L) Table 314. SAMEA Defibrinated Animal Blood Sales Price by Country (2027-2032) & (USD/L) Table 315. Brazil Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 316. Argentina Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 317. Chile Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 318. Colombia Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 319. Peru Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 320. Saudi Arabia Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 321. Israel Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 322. UAE Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 323. Turkey Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 324. Iran Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 325. Egypt Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Table 326. Key Raw Materials Table 327. Raw Materials Key Suppliers Table 328. Defibrinated Animal Blood Distributors List Table 329. Defibrinated Animal Blood Customers List Table 330. Research Programs/Design for This Report Table 331. Authors List of This Report Table 332. Secondary Sources Table 333. Primary Sources List of Figures Figure 1. Defibrinated Animal Blood Image Figure 2. Global Defibrinated Animal Blood Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Defibrinated Animal Blood Market Size Share 2021 VS 2025 VS 2032 Figure 4. Bovine Image Figure 5. Horse Image Figure 6. Rabbit Image Figure 7. Sheep Image Figure 8. Others Image Figure 9. Global Defibrinated Animal Blood Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Defibrinated Animal Blood Market Size Share 2021 VS 2025 VS 2032 Figure 11. Biomedicine Image Figure 12. Research Image Figure 13. Global Defibrinated Animal Blood Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Defibrinated Animal Blood Revenue (2021-2032) & (US$ Million) Figure 15. Global Defibrinated Animal Blood Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Defibrinated Animal Blood Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Defibrinated Animal Blood Revenue Market Share by Region (2021-2032) Figure 18. Global Defibrinated Animal Blood Sales (2021-2032) & (kL) Figure 19. Global Defibrinated Animal Blood Sales by Region: 2021 VS 2025 VS 2032 (kL) Figure 20. Global Defibrinated Animal Blood Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Defibrinated Animal Blood Sales YoY (2021-2032) & (kL) Figure 22. Europe Defibrinated Animal Blood Sales YoY (2021-2032) & (kL) Figure 23. China Defibrinated Animal Blood Sales YoY (2021-2032) & (kL) Figure 24. Asia (Excluding China) Defibrinated Animal Blood Sales YoY (2021-2032) & (kL) Figure 25. South America, Middle East and Africa Defibrinated Animal Blood Sales YoY (2021-2032) & (kL) Figure 26. Global Defibrinated Animal Blood Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Defibrinated Animal Blood Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Defibrinated Animal Blood Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Defibrinated Animal Blood Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Defibrinated Animal Blood Revenue Market Share by Type (2021-2032) Figure 32. Global Defibrinated Animal Blood Sales by Type (2021 VS 2025 VS 2032) & (kL) Figure 33. Global Defibrinated Animal Blood Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Defibrinated Animal Blood Sales Market Share by Type (2021-2032) Figure 35. Global Defibrinated Animal Blood Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Defibrinated Animal Blood Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Defibrinated Animal Blood Revenue Market Share by Application (2021-2032) Figure 38. Global Defibrinated Animal Blood Sales by Application (2021 VS 2025 VS 2032) & (kL) Figure 39. Global Defibrinated Animal Blood Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Defibrinated Animal Blood Sales Market Share by Application (2021-2032) Figure 41. North America Defibrinated Animal Blood Revenue Share by Type (2021-2032) Figure 42. North America Defibrinated Animal Blood Sales Share by Type (2021-2032) Figure 43. North America Defibrinated Animal Blood Revenue Share by Application (2021-2032) Figure 44. North America Defibrinated Animal Blood Sales Share by Application (2021-2032) Figure 45. North America Defibrinated Animal Blood Revenue Share by Country (2021-2032) Figure 46. North America Defibrinated Animal Blood Sales Share by Country (2021-2032) Figure 47. Europe Defibrinated Animal Blood Revenue Share by Type (2021-2032) Figure 48. Europe Defibrinated Animal Blood Sales Share by Type (2021-2032) Figure 49. Europe Defibrinated Animal Blood Revenue Share by Application (2021-2032) Figure 50. Europe Defibrinated Animal Blood Sales Share by Application (2021-2

Scope & coverage.

Types
  • Bovine
  • Horse
  • Rabbit
  • Sheep
  • Others
Applications
  • Biomedicine
  • Research
Companies covered
  • Thermo Fisher Scientific
  • TCS Biosciences
  • BioMérieux
  • E & O Laboratories Ltd
  • Southern Biological
  • Trafalgar Scientific
  • HemoStat Laboratories
  • Dutscher
  • Serana Europe
  • Innovative Research Inc
  • Colorado Serum
  • SSI Diagnostica
  • SR Group
  • Szabo-Scandic
  • Rockland Immunochemicals, Inc.
  • LABone Scientific Co.Ltd.
  • Biowest(BioNordic A/S)
  • Pel-Freez Biologicals
  • EWC Diagnostics
  • Kraeber & Co. GmbH
  • Bio Nutrientes Do Brasil Ltda.
  • Lampire Biological Laboratories, Inc.
  • Quad Five(Materials Bio Inc.)
  • Guangzhou Ruite Biotechnology Co., Ltd.
  • Obio Technology (Shanghai) Corp., Ltd.
  • Beijing Solarbio Science & Technology Co.,Ltd.
  • Nanjing SenBeiJia Biological Technology Co., Ltd.
  • Changde BKMAM Biotechnology Co. Ltd.
  • Beijing Baiao Leibo Technology Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Defibrinated Animal Blood Market by Type
  3. 1.2.1 Global Defibrinated Animal Blood Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Bovine
  5. 1.2.3 Horse
  6. 1.2.4 Rabbit
  7. 1.2.5 Sheep
  8. 1.2.6 Others
  9. 1.3 Defibrinated Animal Blood Market by Application
  10. 1.3.1 Global Defibrinated Animal Blood Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Biomedicine
  12. 1.3.3 Research
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Defibrinated Animal Blood Market Dynamics
  1. 2.1 Defibrinated Animal Blood Industry Trends
  2. 2.2 Defibrinated Animal Blood Industry Drivers
  3. 2.3 Defibrinated Animal Blood Industry Opportunities and Challenges
  4. 2.4 Defibrinated Animal Blood Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Defibrinated Animal Blood Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Defibrinated Animal Blood Revenue by Region
  3. 3.2.1 Global Defibrinated Animal Blood Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Defibrinated Animal Blood Revenue by Region (2021-2026)
  5. 3.2.3 Global Defibrinated Animal Blood Revenue by Region (2027-2032)
  6. 3.2.4 Global Defibrinated Animal Blood Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Defibrinated Animal Blood Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Defibrinated Animal Blood Sales by Region
  9. 3.4.1 Global Defibrinated Animal Blood Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Defibrinated Animal Blood Sales by Region (2021-2026)
  11. 3.4.3 Global Defibrinated Animal Blood Sales by Region (2027-2032)
  12. 3.4.4 Global Defibrinated Animal Blood Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Defibrinated Animal Blood Revenue by Manufacturers
  2. 4.1.1 Global Defibrinated Animal Blood Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Defibrinated Animal Blood Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Defibrinated Animal Blood Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Defibrinated Animal Blood Sales by Manufacturers
  6. 4.2.1 Global Defibrinated Animal Blood Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Defibrinated Animal Blood Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Defibrinated Animal Blood Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Defibrinated Animal Blood Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Defibrinated Animal Blood Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Defibrinated Animal Blood Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Defibrinated Animal Blood Manufacturers, Product Type & Application
  13. 4.7 Global Defibrinated Animal Blood Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Defibrinated Animal Blood Market CR5 and HHI
  16. 4.8.2 2025 Defibrinated Animal Blood Tier 1, Tier 2, and Tier 3
5 Defibrinated Animal Blood Market by Type
  1. 5.1 Global Defibrinated Animal Blood Revenue by Type
  2. 5.1.1 Global Defibrinated Animal Blood Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Defibrinated Animal Blood Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Defibrinated Animal Blood Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Defibrinated Animal Blood Sales by Type
  6. 5.2.1 Global Defibrinated Animal Blood Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Defibrinated Animal Blood Sales by Type (2021-2032) & (kL)
  8. 5.2.3 Global Defibrinated Animal Blood Sales Market Share by Type (2021-2032)
  9. 5.3 Global Defibrinated Animal Blood Price by Type
6 Defibrinated Animal Blood Market by Application
  1. 6.1 Global Defibrinated Animal Blood Revenue by Application
  2. 6.1.1 Global Defibrinated Animal Blood Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Defibrinated Animal Blood Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Defibrinated Animal Blood Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Defibrinated Animal Blood Sales by Application
  6. 6.2.1 Global Defibrinated Animal Blood Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Defibrinated Animal Blood Sales by Application (2021-2032) & (kL)
  8. 6.2.3 Global Defibrinated Animal Blood Sales Market Share by Application (2021-2032)
  9. 6.3 Global Defibrinated Animal Blood Price by Application
7 Company Profiles
  1. 7.1 Thermo Fisher Scientific
  2. 7.1.1 Thermo Fisher Scientific Company Information
  3. 7.1.2 Thermo Fisher Scientific Business Overview
  4. 7.1.3 Thermo Fisher Scientific Defibrinated Animal Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Thermo Fisher Scientific Defibrinated Animal Blood Product Portfolio
  6. 7.1.5 Thermo Fisher Scientific Recent Developments
  7. 7.2 TCS Biosciences
  8. 7.2.1 TCS Biosciences Company Information
  9. 7.2.2 TCS Biosciences Business Overview
  10. 7.2.3 TCS Biosciences Defibrinated Animal Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 TCS Biosciences Defibrinated Animal Blood Product Portfolio
  12. 7.2.5 TCS Biosciences Recent Developments
  13. 7.3 BioMérieux
  14. 7.3.1 BioMérieux Company Information
  15. 7.3.2 BioMérieux Business Overview
  16. 7.3.3 BioMérieux Defibrinated Animal Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 BioMérieux Defibrinated Animal Blood Product Portfolio
  18. 7.3.5 BioMérieux Recent Developments
  19. 7.4 E & O Laboratories Ltd
  20. 7.4.1 E & O Laboratories Ltd Company Information
  21. 7.4.2 E & O Laboratories Ltd Business Overview
  22. 7.4.3 E & O Laboratories Ltd Defibrinated Animal Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 E & O Laboratories Ltd Defibrinated Animal Blood Product Portfolio
  24. 7.4.5 E & O Laboratories Ltd Recent Developments
  25. 7.5 Southern Biological
  26. 7.5.1 Southern Biological Company Information
  27. 7.5.2 Southern Biological Business Overview
  28. 7.5.3 Southern Biological Defibrinated Animal Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Southern Biological Defibrinated Animal Blood Product Portfolio
  30. 7.5.5 Southern Biological Recent Developments
  31. 7.6 Trafalgar Scientific
  32. 7.6.1 Trafalgar Scientific Company Information
  33. 7.6.2 Trafalgar Scientific Business Overview
  34. 7.6.3 Trafalgar Scientific Defibrinated Animal Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Trafalgar Scientific Defibrinated Animal Blood Product Portfolio
  36. 7.6.5 Trafalgar Scientific Recent Developments
  37. 7.7 HemoStat Laboratories
  38. 7.7.1 HemoStat Laboratories Company Information
  39. 7.7.2 HemoStat Laboratories Business Overview
  40. 7.7.3 HemoStat Laboratories Defibrinated Animal Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 HemoStat Laboratories Defibrinated Animal Blood Product Portfolio
  42. 7.7.5 HemoStat Laboratories Recent Developments
  43. 7.8 Dutscher
  44. 7.8.1 Dutscher Company Information
  45. 7.8.2 Dutscher Business Overview
  46. 7.8.3 Dutscher Defibrinated Animal Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Dutscher Defibrinated Animal Blood Product Portfolio
  48. 7.8.5 Dutscher Recent Developments
  49. 7.9 Serana Europe
  50. 7.9.1 Serana Europe Company Information
  51. 7.9.2 Serana Europe Business Overview
  52. 7.9.3 Serana Europe Defibrinated Animal Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Serana Europe Defibrinated Animal Blood Product Portfolio
  54. 7.9.5 Serana Europe Recent Developments
  55. 7.10 Innovative Research Inc
  56. 7.10.1 Innovative Research Inc Company Information
  57. 7.10.2 Innovative Research Inc Business Overview
  58. 7.10.3 Innovative Research Inc Defibrinated Animal Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Innovative Research Inc Defibrinated Animal Blood Product Portfolio
  60. 7.10.5 Innovative Research Inc Recent Developments
  61. 7.11 Colorado Serum
  62. 7.11.1 Colorado Serum Company Information
  63. 7.11.2 Colorado Serum Business Overview
  64. 7.11.3 Colorado Serum Defibrinated Animal Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Colorado Serum Defibrinated Animal Blood Product Portfolio
  66. 7.11.5 Colorado Serum Recent Developments
  67. 7.12 SSI Diagnostica
  68. 7.12.1 SSI Diagnostica Company Information
  69. 7.12.2 SSI Diagnostica Business Overview
  70. 7.12.3 SSI Diagnostica Defibrinated Animal Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 SSI Diagnostica Defibrinated Animal Blood Product Portfolio
  72. 7.12.5 SSI Diagnostica Recent Developments
  73. 7.13 SR Group
  74. 7.13.1 SR Group Company Information
  75. 7.13.2 SR Group Business Overview
  76. 7.13.3 SR Group Defibrinated Animal Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 SR Group Defibrinated Animal Blood Product Portfolio
  78. 7.13.5 SR Group Recent Developments
  79. 7.14 Szabo-Scandic
  80. 7.14.1 Szabo-Scandic Company Information
  81. 7.14.2 Szabo-Scandic Business Overview
  82. 7.14.3 Szabo-Scandic Defibrinated Animal Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Szabo-Scandic Defibrinated Animal Blood Product Portfolio
  84. 7.14.5 Szabo-Scandic Recent Developments
  85. 7.15 Rockland Immunochemicals, Inc.
  86. 7.15.1 Rockland Immunochemicals, Inc. Company Information
  87. 7.15.2 Rockland Immunochemicals, Inc. Business Overview
  88. 7.15.3 Rockland Immunochemicals, Inc. Defibrinated Animal Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Rockland Immunochemicals, Inc. Defibrinated Animal Blood Product Portfolio
  90. 7.15.5 Rockland Immunochemicals, Inc. Recent Developments
  91. 7.16 LABone Scientific Co.Ltd.
  92. 7.16.1 LABone Scientific Co.Ltd. Company Information
  93. 7.16.2 LABone Scientific Co.Ltd. Business Overview
  94. 7.16.3 LABone Scientific Co.Ltd. Defibrinated Animal Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 LABone Scientific Co.Ltd. Defibrinated Animal Blood Product Portfolio
  96. 7.16.5 LABone Scientific Co.Ltd. Recent Developments
  97. 7.17 Biowest(BioNordic A/S)
  98. 7.17.1 Biowest(BioNordic A/S) Company Information
  99. 7.17.2 Biowest(BioNordic A/S) Business Overview
  100. 7.17.3 Biowest(BioNordic A/S) Defibrinated Animal Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Biowest(BioNordic A/S) Defibrinated Animal Blood Product Portfolio
  102. 7.17.5 Biowest(BioNordic A/S) Recent Developments
  103. 7.18 Pel-Freez Biologicals
  104. 7.18.1 Pel-Freez Biologicals Company Information
  105. 7.18.2 Pel-Freez Biologicals Business Overview
  106. 7.18.3 Pel-Freez Biologicals Defibrinated Animal Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Pel-Freez Biologicals Defibrinated Animal Blood Product Portfolio
  108. 7.18.5 Pel-Freez Biologicals Recent Developments
  109. 7.19 EWC Diagnostics
  110. 7.19.1 EWC Diagnostics Company Information
  111. 7.19.2 EWC Diagnostics Business Overview
  112. 7.19.3 EWC Diagnostics Defibrinated Animal Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 EWC Diagnostics Defibrinated Animal Blood Product Portfolio
  114. 7.19.5 EWC Diagnostics Recent Developments
  115. 7.20 Kraeber & Co. GmbH
  116. 7.20.1 Kraeber & Co. GmbH Company Information
  117. 7.20.2 Kraeber & Co. GmbH Business Overview
  118. 7.20.3 Kraeber & Co. GmbH Defibrinated Animal Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Kraeber & Co. GmbH Defibrinated Animal Blood Product Portfolio
  120. 7.20.5 Kraeber & Co. GmbH Recent Developments
  121. 7.21 Bio Nutrientes Do Brasil Ltda.
  122. 7.21.1 Bio Nutrientes Do Brasil Ltda. Company Information
  123. 7.21.2 Bio Nutrientes Do Brasil Ltda. Business Overview
  124. 7.21.3 Bio Nutrientes Do Brasil Ltda. Defibrinated Animal Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Bio Nutrientes Do Brasil Ltda. Defibrinated Animal Blood Product Portfolio
  126. 7.21.5 Bio Nutrientes Do Brasil Ltda. Recent Developments
  127. 7.22 Lampire Biological Laboratories, Inc.
  128. 7.22.1 Lampire Biological Laboratories, Inc. Company Information
  129. 7.22.2 Lampire Biological Laboratories, Inc. Business Overview
  130. 7.22.3 Lampire Biological Laboratories, Inc. Defibrinated Animal Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Lampire Biological Laboratories, Inc. Defibrinated Animal Blood Product Portfolio
  132. 7.22.5 Lampire Biological Laboratories, Inc. Recent Developments
  133. 7.23 Quad Five(Materials Bio Inc.)
  134. 7.23.1 Quad Five(Materials Bio Inc.) Company Information
  135. 7.23.2 Quad Five(Materials Bio Inc.) Business Overview
  136. 7.23.3 Quad Five(Materials Bio Inc.) Defibrinated Animal Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Quad Five(Materials Bio Inc.) Defibrinated Animal Blood Product Portfolio
  138. 7.23.5 Quad Five(Materials Bio Inc.) Recent Developments
  139. 7.24 Guangzhou Ruite Biotechnology Co., Ltd.
  140. 7.24.1 Guangzhou Ruite Biotechnology Co., Ltd. Company Information
  141. 7.24.2 Guangzhou Ruite Biotechnology Co., Ltd. Business Overview
  142. 7.24.3 Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Animal Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  143. 7.24.4 Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Animal Blood Product Portfolio
  144. 7.24.5 Guangzhou Ruite Biotechnology Co., Ltd. Recent Developments
  145. 7.25 Obio Technology (Shanghai) Corp., Ltd.
  146. 7.25.1 Obio Technology (Shanghai) Corp., Ltd. Company Information
  147. 7.25.2 Obio Technology (Shanghai) Corp., Ltd. Business Overview
  148. 7.25.3 Obio Technology (Shanghai) Corp., Ltd. Defibrinated Animal Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  149. 7.25.4 Obio Technology (Shanghai) Corp., Ltd. Defibrinated Animal Blood Product Portfolio
  150. 7.25.5 Obio Technology (Shanghai) Corp., Ltd. Recent Developments
  151. 7.26 Beijing Solarbio Science & Technology Co.,Ltd.
  152. 7.26.1 Beijing Solarbio Science & Technology Co.,Ltd. Company Information
  153. 7.26.2 Beijing Solarbio Science & Technology Co.,Ltd. Business Overview
  154. 7.26.3 Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Animal Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  155. 7.26.4 Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Animal Blood Product Portfolio
  156. 7.26.5 Beijing Solarbio Science & Technology Co.,Ltd. Recent Developments
  157. 7.27 Nanjing SenBeiJia Biological Technology Co., Ltd.
  158. 7.27.1 Nanjing SenBeiJia Biological Technology Co., Ltd. Company Information
  159. 7.27.2 Nanjing SenBeiJia Biological Technology Co., Ltd. Business Overview
  160. 7.27.3 Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Animal Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  161. 7.27.4 Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Animal Blood Product Portfolio
  162. 7.27.5 Nanjing SenBeiJia Biological Technology Co., Ltd. Recent Developments
  163. 7.28 Changde BKMAM Biotechnology Co. Ltd.
  164. 7.28.1 Changde BKMAM Biotechnology Co. Ltd. Company Information
  165. 7.28.2 Changde BKMAM Biotechnology Co. Ltd. Business Overview
  166. 7.28.3 Changde BKMAM Biotechnology Co. Ltd. Defibrinated Animal Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  167. 7.28.4 Changde BKMAM Biotechnology Co. Ltd. Defibrinated Animal Blood Product Portfolio
  168. 7.28.5 Changde BKMAM Biotechnology Co. Ltd. Recent Developments
  169. 7.29 Beijing Baiao Leibo Technology Co., Ltd.
  170. 7.29.1 Beijing Baiao Leibo Technology Co., Ltd. Company Information
  171. 7.29.2 Beijing Baiao Leibo Technology Co., Ltd. Business Overview
  172. 7.29.3 Beijing Baiao Leibo Technology Co., Ltd. Defibrinated Animal Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  173. 7.29.4 Beijing Baiao Leibo Technology Co., Ltd. Defibrinated Animal Blood Product Portfolio
  174. 7.29.5 Beijing Baiao Leibo Technology Co., Ltd. Recent Developments
8 North America
  1. 8.1 North America Defibrinated Animal Blood Market Size by Type
  2. 8.1.1 North America Defibrinated Animal Blood Revenue by Type (2021-2032)
  3. 8.1.2 North America Defibrinated Animal Blood Sales by Type (2021-2032)
  4. 8.1.3 North America Defibrinated Animal Blood Price by Type (2021-2032)
  5. 8.2 North America Defibrinated Animal Blood Market Size by Application
  6. 8.2.1 North America Defibrinated Animal Blood Revenue by Application (2021-2032)
  7. 8.2.2 North America Defibrinated Animal Blood Sales by Application (2021-2032)
  8. 8.2.3 North America Defibrinated Animal Blood Price by Application (2021-2032)
  9. 8.3 North America Defibrinated Animal Blood Market Size by Country
  10. 8.3.1 North America Defibrinated Animal Blood Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Defibrinated Animal Blood Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Defibrinated Animal Blood Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Defibrinated Animal Blood Market Size by Type
  2. 9.1.1 Europe Defibrinated Animal Blood Revenue by Type (2021-2032)
  3. 9.1.2 Europe Defibrinated Animal Blood Sales by Type (2021-2032)
  4. 9.1.3 Europe Defibrinated Animal Blood Price by Type (2021-2032)
  5. 9.2 Europe Defibrinated Animal Blood Market Size by Application
  6. 9.2.1 Europe Defibrinated Animal Blood Revenue by Application (2021-2032)
  7. 9.2.2 Europe Defibrinated Animal Blood Sales by Application (2021-2032)
  8. 9.2.3 Europe Defibrinated Animal Blood Price by Application (2021-2032)
  9. 9.3 Europe Defibrinated Animal Blood Market Size by Country
  10. 9.3.1 Europe Defibrinated Animal Blood Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Defibrinated Animal Blood Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Defibrinated Animal Blood Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Defibrinated Animal Blood Market Size by Type
  2. 10.1.1 China Defibrinated Animal Blood Revenue by Type (2021-2032)
  3. 10.1.2 China Defibrinated Animal Blood Sales by Type (2021-2032)
  4. 10.1.3 China Defibrinated Animal Blood Price by Type (2021-2032)
  5. 10.2 China Defibrinated Animal Blood Market Size by Application
  6. 10.2.1 China Defibrinated Animal Blood Revenue by Application (2021-2032)
  7. 10.2.2 China Defibrinated Animal Blood Sales by Application (2021-2032)
  8. 10.2.3 China Defibrinated Animal Blood Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Defibrinated Animal Blood Market Size by Type
  2. 11.1.1 Asia Defibrinated Animal Blood Revenue by Type (2021-2032)
  3. 11.1.2 Asia Defibrinated Animal Blood Sales by Type (2021-2032)
  4. 11.1.3 Asia Defibrinated Animal Blood Price by Type (2021-2032)
  5. 11.2 Asia Defibrinated Animal Blood Market Size by Application
  6. 11.2.1 Asia Defibrinated Animal Blood Revenue by Application (2021-2032)
  7. 11.2.2 Asia Defibrinated Animal Blood Sales by Application (2021-2032)
  8. 11.2.3 Asia Defibrinated Animal Blood Price by Application (2021-2032)
  9. 11.3 Asia Defibrinated Animal Blood Market Size by Country
  10. 11.3.1 Asia Defibrinated Animal Blood Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Defibrinated Animal Blood Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Defibrinated Animal Blood Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Defibrinated Animal Blood Market Size by Type
  2. 12.1.1 SAMEA Defibrinated Animal Blood Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Defibrinated Animal Blood Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Defibrinated Animal Blood Price by Type (2021-2032)
  5. 12.2 SAMEA Defibrinated Animal Blood Market Size by Application
  6. 12.2.1 SAMEA Defibrinated Animal Blood Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Defibrinated Animal Blood Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Defibrinated Animal Blood Price by Application (2021-2032)
  9. 12.3 SAMEA Defibrinated Animal Blood Market Size by Country
  10. 12.3.1 SAMEA Defibrinated Animal Blood Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Defibrinated Animal Blood Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Defibrinated Animal Blood Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Defibrinated Animal Blood Value Chain Analysis
  2. 13.1.1 Defibrinated Animal Blood Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Defibrinated Animal Blood Production Mode & Process
  6. 13.2 Defibrinated Animal Blood Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Defibrinated Animal Blood Distributors
  9. 13.2.3 Defibrinated Animal Blood Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst